Benoit Lhermitte

Illkirch-graffenstaden, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 93 publications

Glioneuronal Tumour With Neurocytic Differentiation (GNTN): a Molecularly Defined Tumour Type Formerly Referred to as Extraventricular Neurocytoma.

Glioneuronal Tumour With Neurocytic Differentiation (GNTN): a Molecularly Defined Tumour Type Formerly Referred to as Extraventricular Neurocytoma.

Journal: Neuropathology and applied neurobiology

Published: April 20, 2026

Multimodal Approach to a Photopenic Defect on FDOPA PET/MR in a Case of Glioblastoma and its Progression.

Multimodal Approach to a Photopenic Defect on FDOPA PET/MR in a Case of Glioblastoma and its Progression.

Journal: Clinical nuclear medicine

Published: November 27, 2025

Long-Term Quality of Life and Functional Outcome Analysis of Surgically Managed Central Neurocytoma Patients: Results of a Multicenter Study.

Long-Term Quality of Life and Functional Outcome Analysis of Surgically Managed Central Neurocytoma Patients: Results of a Multicenter Study.

Journal: Neurosurgery

Published: May 22, 2025

Structured assessment of brain MRI in Covid-19-related neurological disease: an international multicentre study.

Structured assessment of brain MRI in Covid-19-related neurological disease: an international multicentre study.

Journal: Neuroradiology

Published: May 12, 2025

Challenging CDKN2A assessment in BRAF-altered gliomas: lessons from a pleomorphic xanthoastrocytoma-enriched cohort.

Challenging CDKN2A assessment in BRAF-altered gliomas: lessons from a pleomorphic xanthoastrocytoma-enriched cohort.

Journal: Acta neuropathologica communications

Published: May 12, 2025

Synergistic Effects of Cryotherapy and Radiotherapy in Glioblastoma Treatment: Evidence from a Murine Model.

Synergistic Effects of Cryotherapy and Radiotherapy in Glioblastoma Treatment: Evidence from a Murine Model.

Journal: Cancers

Published: April 11, 2025

Nanopore sequencing as a cutting-edge technology for medulloblastoma classification.

Nanopore sequencing as a cutting-edge technology for medulloblastoma classification.

Journal: Neuro-oncology

Published: December 28, 2024

Correction to: Sclerosing epithelioid fibrosarcoma: a new mesenchymal non-meningothelial tumor involving the central nervous system?

Correction to: Sclerosing epithelioid fibrosarcoma: a new mesenchymal non-meningothelial tumor involving the central nervous system?

Journal: Virchows Archiv : an international journal of pathology

Published: December 10, 2024

Cerebromeningeal amyloid angiopathy

Cerebromeningeal amyloid angiopathy

Journal: Annales de pathologie

Published: September 03, 2024

Clinical impact of large genomic explorations at diagnosis in 198 pediatric solid tumors: a monocentric study aiming practical feasibility of precision oncology.

Clinical impact of large genomic explorations at diagnosis in 198 pediatric solid tumors: a monocentric study aiming practical feasibility of precision oncology.

Journal: BMC cancer

Published: June 03, 2024

Fulminant leptomeningeal disease diagnosed as comutant H3F3A and FGFR diffuse midline glioma.

Fulminant leptomeningeal disease diagnosed as comutant H3F3A and FGFR diffuse midline glioma.

Journal: Annals of clinical and translational neurology

Published: May 21, 2024

Sclerosing epithelioid fibrosarcoma: a new mesenchymal non-meningothelial tumor involving the central nervous system?

Sclerosing epithelioid fibrosarcoma: a new mesenchymal non-meningothelial tumor involving the central nervous system?

Journal: Virchows Archiv : an international journal of pathology

Published: April 16, 2024

Showing 1-12 of 93

Last Updated: 09/26/2026